Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-009012
Filing Date
2017-08-21
Accepted
2017-08-21 16:36:20
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0617_americanbrivision.htm 10-Q 337097
2 CERTIFICATION f10q0617ex31-1_american.htm EX-31.1 14750
3 CERTIFICATION f10q0617ex31-2_american.htm EX-31.2 14358
4 CERTIFICATION f10q0617ex32-1_american.htm EX-32.1 5409
5 CERTIFICATION f10q0617ex32-2_american.htm EX-32.2 5482
  Complete submission text file 0001213900-17-009012.txt   2879755

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20170630.xml EX-101.INS 511011
7 XBRL SCHEMA FILE mtoo-20170630.xsd EX-101.SCH 33268
8 XBRL CALCULATION FILE mtoo-20170630_cal.xml EX-101.CAL 24943
9 XBRL DEFINITION FILE mtoo-20170630_def.xml EX-101.DEF 101459
10 XBRL LABEL FILE mtoo-20170630_lab.xml EX-101.LAB 222056
11 XBRL PRESENTATION FILE mtoo-20170630_pre.xml EX-101.PRE 196067
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 171043427
SIC: 2834 Pharmaceutical Preparations